美罗培南
微生物学
大肠杆菌
碳青霉烯
生物
抗生素耐药性
头孢菌素
克雷伯菌
质粒
肠杆菌科
抗生素
基因
遗传学
作者
Kobra Salimiyan Rizi,Ehsan Aryan,Masoud Youssefi,Kiarash Ghazvini,Zahra Meshkat,Yousef Amini,Hadi Safdari,Mohammad Derakhshan,Hadi Farsiani
标识
DOI:10.2217/fmb-2021-0211
摘要
Aim: This study aimed to investigate the role of AmpC enzymes in carbapenem resistance among AmpC/extended-spectrum β-lactamase (ESBL)-producing clinical isolates of Escherichia coli and Klebsiella spp. Methods: Fifty-six bacterial strains that were AmpC producers were examined. The antibiotic susceptibility test was performed by the disk diffusion and E-test. The prevalence of the plasmid carbapenemase was determined using PCR. Results: The resistance to meropenem in the AmpC+/ESBL+ group was 64%, higher than that reported for the AmpC-/ESBL+ group. Ten isolates of the carbapenem-resistant AmpC producers were negative for carbapenemase-encoding genes. Conclusion: Carbapenem resistance among AmpC-producing isolates with negative results for carbapenemase-encoding genes potentially demonstrates the role of AmpC enzymes among these isolates.
科研通智能强力驱动
Strongly Powered by AbleSci AI